Hospitalisation and mortality risk of SARS-COV-2 variant omicron sub-lineage BA.2 compared to BA.1 in EnglandArticle Published on 2022-10-132022-11-16 Journal: Nature Communications [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI confounders country COVID-19 case death dominant variant England hazard hospital Hospital admission hospitalisation Infection investigated large cohort mortality risk multivariable omicron outcome public health regression models risk SARS-CoV-2 stratified variant variant of SARS-CoV-2 [DOI] 10.1038/s41467-022-33740-9 PMC 바로가기
SARS-CoV-2 seroprevalence at urban and rural sites in Kaduna State, Nigeria, during October/November 2021, immediately prior to detection of the Omicron variantArticle Published on 2022-10-132022-11-15 Journal: International Journal of Epidemiology [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] African age antibodies baseline conducted country COVID-19 detectable determine dry cough female Fever groups headache highlight household size indicate individuals infection rate infection rates Kaduna limitation Logistic regression nausea Nigeria omicron participant PCR-confirmed polymerase chain proportion provide public health Reporting SARS-CoV-2 SARS-CoV-2 antibody SARS-COV-2 infection SARS-CoV-2 seroprevalence sense of taste seropositive status seroprevalence. Serosurvey Sex sore throat Spread state stratified subgroup Symptom tested variant were used [DOI] 10.1093/ije/dyac141 PMC 바로가기
Optimizing the implementation of a participant-collected, mail-based SARS-CoV-2 serological survey in university-affiliated populations: lessons learned and practical guidanceArticle Published on 2022-10-122022-11-15 Journal: BMC Public Health [Category] COVID19(2023년), SARS, 진단, [키워드] antibody applicability approach Blood change distribution driven by enrolled Epidemiologic methods feasibility Field epidemiology Future Guidance highlight identify implementation Laboratory Massachusetts Pathogens pre-symptomatic Prevalence recruitment Research SARS-CoV-2 SARS-CoV-2 antibody serological survey serological test serology Serosurveys. Spread stratified Study design Study participants subclinical infection symptomatic individual USA utility virus [DOI] 10.1186/s12889-022-14234-1 PMC 바로가기
Vaccine effectiveness of primary series and booster doses against covid-19 associated hospital admissions in the United States: living test negative design studyArticle Published on 2022-10-112022-11-16 Journal: The BMJ [Category] COVID19(2023년), SARS, 변종, [키워드] 95% confidence interval acute respiratory symptom analysis benefit BNT162b2 booster booster dose case-control study controls dominant Effectiveness evaluated Evidence hospital Hospital admission Immunocompromised Immunocompromised patients Immunosuppression interquartile range laboratory confirmed covid-19 median age mRNA vaccine mRNA-1273 occur Omicron variant outcome participant Participants Patient primary analysis provided regimen SARS-CoV-2 secondary analysis stratified test negative tested The United States Vaccine [DOI] 10.1136/bmj-2022-072065 PMC 바로가기
Imbalanced Angiogenesis in Pregnancies Complicated by SARS-CoV-2 InfectionArticle Published on 2022-10-072022-11-15 Journal: Viruses [Category] COVID19(2023년), SARS, 바이오마커, [키워드] Admission age angiogenic factors antithrombotic therapy Asymptomatic asymptomatic patient clinically collected COVID-19 cut-off value death diagnosed Diagnosis diagnosis of SARS-CoV-2 dysfunction dysregulation endothelial Endothelial dysfunction evaluate Factors FGR gestation growth factor hospital incidence Infection intensive care management marker mother Neonatal Neonate not significantly different Patient placental placental dysfunction preeclampsia Pregnancy pregnant population pregnant women proportion RAS reported resulting Retrospective analysis SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 positive asymptomatic Serum level severity sFlt-1. Stillbirth stratified Symptom symptomatic symptomatic patient symptoms of COVID-19 turn tyrosine was performed with COVID-19 women [DOI] 10.3390/v14102207 PMC 바로가기
Palmitoylethanolamide Reduces Proinflammatory Markers in Unvaccinated Adults Recently Diagnosed with COVID-19: A Randomized Controlled TrialArticle Published on 2022-10-062022-11-15 Journal: The Journal of Nutrition [Category] COVID19(2023년), SARS, 바이오마커, [키워드] adhesion molecules age anti-inflammatory effect Antigen assigned baseline Biomarker Blood BMI C-reactive protein CDC chronic condition coin toss Concentration conducted Controlled coronavirus disease covariates COVID-19 COVID-19 complications COVID-19, SARS-COV-2 Cytokines diagnosed with COVID-19 Diagnosis dietary supplements double-blind dysregulated immune response Effect exacerbate ferritin group Health IL-1β IL-2 IL-6 implicated indicated individual infected with COVID-19 infections infectious conditions Inflammation inflammatory mediator intercellular Linear regression model mechanism Multiple outcomes P-selectin palmitoylethanolamide palmitoylethanolamide. participant Placebo placebo tablet positive test result Primary outcome produced proinflammatory promote randomized placebo-controlled trial Randomly receive reduced reported RT-PCR secretion severity Sex significantly stratified treatment effect [DOI] 10.1093/jn/nxac154 PMC 바로가기
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, CanadaArticle Published on 2022-10-032022-11-16 Journal: JAMA Network Open [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] 95% CI adjusted Against age Care case-control study conducted dose doses Estimated female genomic greater Health Heterologous Hospitalization individual individuals Infection laboratory-confirmed laboratory-confirmed SARS-CoV-2 infection messenger Messenger RNA mRNA mRNA vaccination mRNA vaccine Odds ratio Older omicron outcome participant Participants phylogenetically Postinfection Prevent protection provided quantification Quebec, Canada reduction Reinfection risk risk reduction SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant severity Sex significantly higher stratified Surveillance tested vaccinated individual vaccination Vaccine vaccine dose vaccine strain variant [DOI] 10.1001/jamanetworkopen.2022.36670 PMC 바로가기
HIV suppression was maintained during the COVID-19 pandemic in Malawi: a program-level cohort studyResearch article Published on 2022-10-012022-10-05 Journal: Journal of clinical epidemiology [Category] COVID19(2023년), SARS, 치료기술, [키워드] 95% CI adjusted adjusted odds ratio age Antiretroviral therapy ART Care clinics cohort study collected COVID-19 COVID-19 epidemic COVID-19 pandemic Critical declined Evidence examined Government HIV introduced logistic regression models Malawi measure multiple imputation National NNRTI no difference objective outcome pandemic Patient patients population-based cohort predictor protease reduce reduced regimen regimens Result routine SARS-CoV-2 Sex Spread stratified Support Suppression of HIV replication transcriptase transfer Treatment Treatment outcome treatment regimen Viral load VL testing with HIV [DOI] 10.1016/j.jclinepi.2022.06.019 [Article Type] Research article
Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational studyArticle Published on 2022-10-012022-11-15 Journal: Breast cancer research and treatment [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] Affect Breast Breast cancer breast cancer patient breast cancer patients Cancer cancer treatment CDK4/6 Chemotherapy collected COVID-19 Efficacy enrolled epidermal first vaccination five group growth factor Infection Infection prevention inhibitor inhibitors investigated Japan lowest neutralizing antibody Neutralizing antibody titer Omicron variant pandemic Patient Prevent prospective observational study raising receptor reduction reduction in SARA-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 variant second vaccination Seroconversion seroconversion rate serological response serum sample stratified suggested Support the patient the SARS-CoV-2 therapy Treatment vaccination vaccination efficacy Vaccine vaccine. variant wild-type [DOI] 10.1007/s10549-022-06693-2 PMC 바로가기
Safety and efficacy of COVID-19 vaccines in children and adolescents: A systematic review of randomized controlled trials소아 및 청소년에 대한 COVID-19 백신의 안전성 및 효능: 무작위 대조 시험의 체계적인 검토Review Published on 2022-10-012022-09-11 Journal: Journal of medical virology [Category] Fulltext, MERS, 임상, [키워드] Abstract age Analysis bias risk children Children and adolescents Chinese clinical clinical trial Cochrane Library code common adverse event common adverse events coronavirus coronavirus disease cough COVID-19 COVID-19 infection COVID-19 vaccine COVID-19 vaccines data extraction Efficacy evaluated fatigue Fever groups headache ICTRP immunization Injection-site pain investigated Local Messenger RNA Microsoft Excel Mild mild to moderate moderate MOST mRNA mRNA vaccine mRNA vaccines muscle pain Pain participant pediatric Placebo profile Randomized controlled trial Randomized controlled trials RCT RCTs reaction Reactions registry reported Safety searched Serious Adverse Events Seven stratified suggested systematic review systematic review. systemic adverse event the vaccine title Trial vaccination Vaccine was used Web of Science website were used [DOI] 10.1002/jmv.27940 PMC 바로가기 [Article Type] Review